Valuation check: GNFT's profit margin is -8.07%, below the Healthcare sector average of 13.71%.
Get informed when a big investor buys or sells
+ FollowAs of Jun 2025
Trailing 12 months ending Jun 2025
Genfit (GNFT) currently reports a profit margin of -8.07% as of June 2025. That compares with -111.3% in the prior-year period — up 92.7% year over year. That is below the Healthcare sector average of 13.71%. Use the charts on this page to explore Genfit's profit margin history and peer comparisons.
Genfit's profit margin increased from -111.3% to -8.07% — a 92.7% year-over-year increase (period ending June 2025). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.
Genfit's profit margin of -8.07% is lower than the Healthcare sector average of 13.71%. That is roughly 158.9% below the sector mean. A reading lower peers can reflect different growth expectations, capital structure, or profitability — so it is worth checking the peer comparison chart before drawing conclusions.
There is no universal 'good' profit margin, but Genfit's current -8.07% should be judged against Healthcare norms (sector average: 13.71%) and against GNFT's own history. Strong, stable readings often indicate durable competitive advantage; volatile or declining ones deserve a closer look at margins and capital efficiency.
Start with the current profit margin of -8.07%, then check the historical chart for trend and the peer comparison chart for relative positioning. The Healthcare average is 13.71%. From there, open related valuation or income-statement pages for Genfit, and consider following GNFT for alerts when major investors trade the stock.